P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY
- DOI
- 10.1097/01.hs9.0000847576.88118.d6
- Published
- 2022-06
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000847576.88118.d6,
title = {P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY},
author = {N. L. Bartlett and C. A. Yasenchak and K. K. Ashraf and W. N. Harwin and J. Orcutt and P. Kuriakose and P. L. Zinzani and A. Mamidipalli and K. Fenton and C. Glenn and G. Nowakowski},
year = {2022},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000847576.88118.d6},
url = {https://doi.org/10.1097/01.hs9.0000847576.88118.d6}
}RIS
TY - JOUR TI - P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY AU - N. L. Bartlett AU - C. A. Yasenchak AU - K. K. Ashraf AU - W. N. Harwin AU - J. Orcutt AU - P. Kuriakose AU - P. L. Zinzani AU - A. Mamidipalli AU - K. Fenton AU - C. Glenn AU - G. Nowakowski PY - 2022 JO - HemaSphere DO - 10.1097/01.hs9.0000847576.88118.d6 UR - https://doi.org/10.1097/01.hs9.0000847576.88118.d6 ER -
APA
Bartlett, N. L., Yasenchak, C. A., Ashraf, K. K., Harwin, W. N., Orcutt, J., Kuriakose, P., Zinzani, P. L., Mamidipalli, A., Fenton, K., Glenn, C., & Nowakowski, G. (2022). P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY. HemaSphere. https://doi.org/10.1097/01.hs9.0000847576.88118.d6
Source records
- crossref · retrieved 2026-09-26T07:15:14.030Z